Evidence map›Paper›PMID 38960694›Full record

ArticleInternal medicine (Tokyo, Japan)2025

Autopsy Case of Epstein-Barr Virus-associated T-cell Post-transplant Lymphoproliferative Disorder with Mono- and Polymorphic Lesions: Possibility of 'Polymorphic T-cell Post-transplant Lymphoproliferative Disorder'.

Keijiro Sato, Toshimitsu Ueki, Takayoshi Tokutake, Masahide Watanabe, Shohei Shigeto, Hiroyuki Kanno, Masahiko Sumi, Hikaru Kobayashi

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Keijiro SatoDepartment of Hematology, Nagano Red Cross Hospital, Japan.
Toshimitsu UekiDepartment of Hematology, Nagano Red Cross Hospital, Japan.
Takayoshi TokutakeDepartment of Clinical Laboratory, Nagano Red Cross Hospital, Japan.
Masahide WatanabeDepartment of Pathology, Nagano Red Cross Hospital, Japan.
Shohei ShigetoDepartment of Laboratory Medicine, Shinshu University Hospital, Japan.
Hiroyuki KannoDepartment of Pathology, Nagano Red Cross Hospital, Japan.
Masahiko SumiDepartment of Hematology, Nagano Red Cross Hospital, Japan.
Hikaru KobayashiDepartment of Hematology, Nagano Red Cross Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disease (PTLD) is predominantly of B cell origin. The concept of clonal evolution from poly- to monoclonal lymphoproliferation has been put forward, but T-cell PTLDs are rare with an unknown etiology. In a unique autopsy case of a 53-year-old man with EBV-associated T-cell PTLD, we observed polymorphic T-cell proliferation across several organs and monomorphic T-cell proliferation in the perforated ileum. Interestingly, both manifestations exhibited identical monoclonal peaks in the T-cell receptor rearrangement polymerase chain reaction (PCR) analyses. These findings suggest the existence of clonal evolution in EBV-associated T-cell PTLD, leading to the proposal of the novel concept of polymorphic T-cell PTLD.

Indexed as

Epstein-Barr Virus InfectionsHerpesvirus 4, HumanLymphoproliferative DisordersPostoperative ComplicationsT-LymphocytesAutopsyFatal OutcomeHumansMaleMiddle AgedEpstein-Barr virushemophagocytic syndromepolymorphicpost-transplant lymphoproliferative disorderT cell

Identifiers

PMID38960694
PMCPMC11867758

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.